Ituxredi
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ituxredi, covering 2025-07-09 to 2025-07-09. Get the full timeline:
Most recent: EMA Authorised: Ituxredi (rituximab) — Reddy Holding GmbH
1 regulatory and trial event tracked for Ituxredi, covering 2025-07-09 to 2025-07-09. Get the full timeline:
Most recent: EMA Authorised: Ituxredi (rituximab) — Reddy Holding GmbH